Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ocular Therapeutix
Marketing
EyePoint sues Ocular for defamation in retina drug race
A pair of rivals developing drugs for common retinal diseases are not seeing eye to eye.
Andrea Park
Mar 23, 2026 11:40am
Ocular's ophthalmologic version of Inlyta bests Eylea in ph. 3
Feb 17, 2026 12:15pm
Ocular hires Eylea launch architect to challenge Regeneron
Jan 23, 2026 10:00am
Ocular Therapeutix sharpens focus with retina-centric rebrand
Jun 27, 2025 10:05am
FDA clears Ocular's Dextenza for eye itching from allergies
Oct 12, 2021 10:20am
Regeneron scraps sustained-release Eylea alliance with Ocular
Aug 10, 2021 8:45am
